These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34051184)

  • 1. Is it the end of mouthwash as an intervention for gonorrhoea?
    Chow EPF; Fairley CK
    Lancet Infect Dis; 2021 Jun; 21(6):763-764. PubMed ID: 34051184
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial.
    Chow EPF; Williamson DA; Hocking JS; Law MG; Maddaford K; Bradshaw CS; McNulty A; Templeton DJ; Moore R; Murray GL; Danielewski JA; Wigan R; Chen MY; Guy RJ; Zhang L; Donovan B; Grulich AE; Kaldor JM; Whiley DM; Cornelisse VJ; Howden BP; Lewis DA; Read TRH; Fairley CK
    Lancet Infect Dis; 2021 May; 21(5):647-656. PubMed ID: 33676595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could antiseptic mouthwash inhibit pharyngeal
    Chow EPF; Fairley CK
    Sex Transm Infect; 2017 Sep; 93(6):403. PubMed ID: 28827305
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiseptic mouthwash against pharyngeal
    Chow EP; Howden BP; Walker S; Lee D; Bradshaw CS; Chen MY; Snow A; Cook S; Fehler G; Fairley CK
    Sex Transm Infect; 2017 Mar; 93(2):88-93. PubMed ID: 27998950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential effect of antiseptic mouthwash on the incidence of
    Xu X; Chow EPF; Shen M; Zou Z; Wang C; Ong JJ; Fairley CK; Zhang L
    BMJ Open; 2021 Oct; 11(10):e052823. PubMed ID: 34620667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, parallel-group, randomised controlled trial of antiseptic mouthwash versus antibiotics for oropharyngeal gonorrhoea treatment (OMEGA2).
    Chow EPF; Maddaford K; Hocking JS; Bradshaw CS; Wigan R; Chen MY; Howden BP; Williamson DA; Fairley CK
    Sci Rep; 2020 Nov; 10(1):19386. PubMed ID: 33168910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating mouthwash use for gonorrhoea prevention into a public health campaign: identifying current knowledge and research gaps.
    Chow EPF; Maddaford K; Trumpour S; Fairley CK
    Sex Health; 2019 Sep; 16(5):433-441. PubMed ID: 31099331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria gonorrhoeae Transmission Among Men Who Have Sex With Men: An Anatomical Site-Specific Mathematical Model Evaluating the Potential Preventive Impact of Mouthwash.
    Zhang L; Regan DG; Chow EPF; Gambhir M; Cornelisse V; Grulich A; Ong J; Lewis DA; Hocking J; Fairley CK
    Sex Transm Dis; 2017 Oct; 44(10):586-592. PubMed ID: 28876289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposing an antibacterial mouthwash to prevent gonorrhoea is not sexy.
    Rotsaert A; Reyniers T; Van Dijck C; Vuylsteke B; Kenyon C
    Lancet Infect Dis; 2021 Jul; 21(7):909. PubMed ID: 34174229
    [No Abstract]   [Full Text] [Related]  

  • 10. Self-Reported Use of Mouthwash and Pharyngeal Gonorrhoea Detection by Nucleic Acid Amplification Test.
    Chow EPF; Walker S; Read TRH; Chen MY; Bradshaw CS; Fairley CK
    Sex Transm Dis; 2017 Oct; 44(10):593-595. PubMed ID: 28876323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for topical antiseptics in the treatment of gonorrhoea?
    Miari VF; Ison CA
    Sex Transm Infect; 2017 Mar; 93(2):79-80. PubMed ID: 28039432
    [No Abstract]   [Full Text] [Related]  

  • 12. New thinking on gonorrhoea control in MSM: are antiseptic mouthwashes the answer?
    Fairley CK; Zhang L; Chow EPF
    Curr Opin Infect Dis; 2018 Feb; 31(1):45-49. PubMed ID: 29176445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between oral sex practices and frequent mouthwash use in men who have sex with men: implications for gonorrhoea prevention.
    Phillips T; Fairley CK; Walker S; Chow EPF
    Sex Health; 2019 Sep; 16(5):473-478. PubMed ID: 30558710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antiplaque efficacy of two cetylpyridinium chloride-containing mouthwashes.
    Barnes VM; Arvanitidou E; Szewczyk G; Richter R; DeVizio W; Cronin M; Michelle S
    J Clin Dent; 2011; 22(6):200-3. PubMed ID: 22403976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical study to assess the 12-hour antimicrobial effects of cetylpyridinium chloride mouthwashes on supragingival plaque bacteria.
    He S; Wei Y; Fan X; Hu D; Sreenivasan PK
    J Clin Dent; 2011; 22(6):195-9. PubMed ID: 22403975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two alcohol-free cetylpyridinium chloride mouthwashes - a randomized double-blind crossover study.
    Rawlinson A; Pollington S; Walsh TF; Lamb DJ; Marlow I; Haywood J; Wright P
    J Clin Periodontol; 2008 Mar; 35(3):230-5. PubMed ID: 18190554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of two mouthwashes on 3-day supragingival plaque regrowth: a randomized crossover clinical trial.
    Marchetti E; Casalena F; Capestro A; Tecco S; Mattei A; Marzo G
    Int J Dent Hyg; 2017 Feb; 15(1):73-80. PubMed ID: 26522915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 0.2% chlorhexidine mouthwash with an antidiscoloration system versus 0.2% chlorhexidine mouthwash: a prospective clinical comparative study.
    Solís C; Santos A; Nart J; Violant D
    J Periodontol; 2011 Jan; 82(1):80-5. PubMed ID: 20653433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
    Coughlan EP; Franklin RA
    N Z Med J; 1996 Mar; 109(1017):82. PubMed ID: 8606827
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of mouthwashes without anti-gonococcal activity for controlled clinical trials: an in vitro study.
    Van Dijck C; Cuylaerts V; Sollie P; Spychala A; De Baetselier I; Laumen J; Crucitti T; Kenyon C
    F1000Res; 2019; 8():1620. PubMed ID: 32089824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.